Looking for work but struggling to land a job interview? Money might help. Some job seekers are paying recruiters to help get a foot in the door, a practice known as "reverse recruitment" in which ...
Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...
Pirtobrutinib (Jaypirca®), a first-in-class noncovalent Bruton tyrosine kinase (BTK) inhibitor, has been approved by the US Food and Drug Administration (FDA) for adults with relapsed or refractory ...
Imre Szenttornyay, CEO of Cielo IT LLC, empowers business owners to scale their operations profitably with AI-powered SmartSigns technology. When you manage a network of retail or franchise locations, ...
Zanubrutinib demonstrates prolonged progression-free survival in relapsed/refractory CLL/SLL, with a median PFS of 52.5 months and 49.9 months for patients with del17p. The ALPINE trial confirms ...
Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...
Pirtobrutinib significantly improved progression-free survival in treatment-naive CLL/SLL patients, reducing disease progression risk by 80% compared to bendamustine plus rituximab. The trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results